NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Tennis Elbow


Reports outline clinical trial research research from J.A. Paoloni and colleagues



NewsRx
Tennis Elbow Library
Library Home

This article was published in Biotech Business Week, which you can subscribe to online.

NewsRx
NewsRx
2009 JUN 8 - (NewsRx.com) -- "This study aimed to determine whether a new glyceryl trinitrate patch preparation is effective in treating chronic lateral epicondylosis. Randomised double-blind controlled clinical trial," investigators in Kogarah, Australia report.

"Private practice patients: 154 adult patients with chronic lateral epicondylosis were recruited, with 136 patients completing the trial. 8 weeks of glyceryl trinitrate patch application (dosages of 72 mg/24 h, 1.44 mg/24 h, and 3.6 mg/24 h), or placebo patch application. Subjective global assessment of change in elbow symptoms, patient-rated tennis elbow evaluation, visual analogue pain at rest, visual analogue pain with activity, visual analogue pain intensity, grip strength, and strength testing using the Orthopaedic Research Institute-Tennis Elbow Testing System. At 8 weeks there was a significant decrease in elbow pain with activity in the glyceryl trinitrate 0.72 mg/24 h group compared with placebo (p=0.04). There were no other significant differences. Continuous 1.25 mg/24 h topical glyceryl trinitrate treatment, when combined with daily exercise rehabilitation, has previously demonstrated efficacy in treating chronic lateral epicondylosis. There was significantly decreased elbow pain with activity at 8 weeks in the glyceryl trinitrate 0.72 mg/24 h group (p=0.04)," wrote J.A. Paoloni and colleagues.

The researchers concluded: "This short-term dose-ranging study did not demonstrate a treatment effect of a new topical glyceryl trinitrate patch in dosages of 1.44 mg/24 h or 3.6 mg/24 h, which conflicts with previous studies on topical glyceryl trinitrate treatment."

Paoloni and colleagues published their study in British Journal of Sports Medicine (Randomised, double-blind, placebo-controlled clinical trial of a new topical glyceryl trinitrate patch for chronic lateral epicondylosis. British Journal of Sports Medicine, 2009;43(4):299-302).

For additional information, contact J.A. Paoloni, Orthopedic Research Institute, 2nd Floor, 4 South St., Kogarah, NSW 2217, Australia.

The publisher of the British Journal of Sports Medicine can be contacted at: B M J Publishing Group, British Med Association House, Tavistock Square, London WC1H 9JR, England.

Keywords: Australia, Kogarah, Clinical Trial Research, Orthopedics, Tennis Elbow.

This article was prepared by Biotech Business Week editors from staff and other reports. Copyright 2009, Biotech Business Week via NewsRx.com.

NewsRx Passes
Advertisement
------------------------
Security by Verisign PR Login